NYSE: HQH - Tekla Healthcare Investors

Yield per half year: -11.74%
Dividend yield: +12.04%
Sector: Financials

Share chart Tekla Healthcare Investors

Extended chart Simple chart
Financial Markets by TradingView

About Tekla Healthcare Investors

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies.

more details
It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 1988-01-05
ISIN US87911J1034
Industry Capital Markets
Sector Financials
Валюта usd
Валюта отчета usd
Див.доход ао 14.42
Дивиденд ао 2.85
Сайт https://www.teklacap.com/hqh.html
Цена ао 16.58
Change price per day: -0.3396% (16.49)
Change price per week: -1.71% (16.72)
Change price per month: -4.51% (17.21)
Change price per 3 month: -0.158% (16.46)
Change price per half year: -11.74% (18.62)
Change price per year: -2.53% (16.86)
Change price per 3 year: -19.83% (20.5)
Change price per 5 year: -17.67% (19.96)
Change price per year to date: -0.2186% (16.47)
All parameters

Underestimation

Title Value Grade
P/S 90.13 1
P/BV 0.9161 9
P/E 5.25 10
EV/EBITDA 13.69 7
Total: 7.25

Efficiency

Title Value Grade
ROA, % 18.56 6
ROE, % 18.58 6
Total: 5.67

Dividends

Title Value Grade
Div yield, % 12.04 10
DSI 0.8571 8.57
Total: 7.8

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % -95.57 0
Yield Ebitda, % -138.77 0
Yield EPS, % -34.9 0
Total: 0
More

More

Institutions Volume Share, %
Morgan Stanley 3021776 6.25
Saba Capital Management, L.P. 1424346 2.95
Cornerstone Advisors, LLC 732299 1.51
AQR Arbitrage LLC 500418 1.03
Royal Bank of Canada 469916 0.97
RPO LLC 382486 0.79
Clough Capital Partners, LP 323228 0.67
BOOTHBAY FUND MANAGEMENT, LLC 312251 0.65
Logan Stone Capital, LLC 297287 0.61
Eschler Asset Management LLP 263560 0.55

ETFShare, %Profitability for 1 year, %Dividends, %
First Trust Income Opportunities ETF 3.34939 18.3 2.48805
Amplify High Income ETF 3.10824 6.94 2.77149
Saba Closed End Funds ETF 2.13068 17.31 2.29022
2.8614.182.52



Head Job title Payment Year of birth
Dr. Daniel R. Omstead M.S, Ph.D. Portfolio Manager N/A 1953 (72 years)
Dr. Jason C. Akus M.B.A., M.D., MBA Vice President of Research and Portfolio Manager N/A
Mr. Christopher F. Brinzey MBA Senior Vice President of Research and Portfolio Manager N/A
Dr. Frank T. Gentile Ph.D. Senior Vice President of Research and Portfolio Manager N/A 1962 (63 years)

Address: United States, Boston. MA, 100 Federal Street - open in Google maps, open in Yandex maps
Website: https://www.teklacap.com/hqh.html